Harris, D., Lacey, A., Akbari, A., Obaid, D., Smith, D. A., Jenkins, G. H., . . . Halcox, J. (2019). Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort. Journal of the American Heart Association, 8(21), p. A74. doi:10.1161/jaha.119.012812

Harris, Daniel, Arron Lacey, Ashley Akbari, Daniel Obaid, Dave A. Smith, Geraint H. Jenkins, James P. Barry, Michael Gravenor, and Julian Halcox. "Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort." Journal of the American Heart Association 8, no. 21 (2019): A74.

Harris, Daniel, et al. "Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort." Journal of the American Heart Association 8.21 (2019): A74.